Trial of Enteric-Coated Camoquin in Intestinal Amebiasis

Mark T. Hoekenga
Search for other papers by Mark T. Hoekenga in
Current site
Google Scholar
PubMed
Close
and
Quintin Gonzalo Maximo
Search for other papers by Quintin Gonzalo Maximo in
Current site
Google Scholar
PubMed
Close
Restricted access

Summary

Enteric-coated Camoquin proved ineffectual in the treatment of intestinal amebiasis in 15 individuals; only 4 or 27 per cent were apparently cured even with total dosages as high as 11.4 Gm. The drug was equally ineffectual in treatment of the Trichomonas hominis that 8 of these patients harbored. Two-thirds of the patients had definite symptoms of toxicity with dizziness being the most pronounced and frequent complaint. As a result of these observations, enteric-coated Camoquin is not recommended for the treatment of intestinal amebiasis.

Save